Vincent LeVien
About Vincent LeVien
Independent Class II director at Celularity since June 2025 (term expiring at the 2026 annual meeting). Age 49. Background spans government affairs and lobbying: Chairman & CEO of I Got a Guy, Inc. since 2011; registered lobbyist for the Roman Catholic Diocese of Brooklyn and DeSales Media Group at NYC/NY State/federal levels; previously Director of Intergovernmental & Community Affairs for the Office of NYS Comptroller Thomas P. DiNapoli (2007–2011) . The board has determined all directors other than the CEO are independent, which includes Mr. LeVien .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| I Got a Guy, Inc. | Chairman & CEO | 2011–present | Network consulting, government relations |
| Roman Catholic Diocese of Brooklyn; DeSales Media Group | Registered lobbyist (NYC/NY State/Federal) | 2011–present | Public policy advocacy; government interface |
| Office of NYS Comptroller (Thomas P. DiNapoli) | Director, Intergovernmental & Community Affairs | 2007–2011 | Led intergovernmental/community affairs |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| — | No other public company directorships disclosed in CELU filings | — | Based on Mr. LeVien’s biography in the 2025 proxy and his June 2025 appointment 8‑K |
Board Governance
- Committee assignments: Audit Committee (Chair); Nominating & Corporate Governance Committee (Member). Appointed to Audit and Nominating committees upon joining in June 2025; listed as Audit Chair in the 2025 proxy .
- Independence: Board classifies all directors except the CEO as independent (includes Mr. LeVien) .
- Audit Committee financial expert: Mr. LeVien is designated as the audit committee financial expert and meets Nasdaq financial sophistication requirements .
- Audit Committee scope includes oversight of related-person transactions, financial reporting, and cybersecurity/data privacy risk management .
- Board/committee activity context: In 2024 the Audit Committee held 7 meetings; Compensation 2; Nominating 3. Each director attended ≥75% of applicable meetings in 2024 (note: predates Mr. LeVien’s appointment) .
Fixed Compensation
| Component | Amount/Terms |
|---|---|
| Annual board retainer (cash) | $45,000 |
| Committee member retainers (cash) | Audit $10,000; Compensation $8,000; Nominating $5,000 |
| Committee chair retainers (cash) | Audit $20,000; Compensation $16,000; Nominating $10,000 |
Notes: Policy caps non-employee director pay at $750,000/year ($1,000,000 in first calendar year as director) .
Performance Compensation
| Equity Element | Terms/Scale |
|---|---|
| Annual equity award | $300,000 total value; 50% options and 50% RSUs; granted on annual meeting date to continuing non-employee directors |
| Initial equity grant (upon joining board) | $300,000 in options; vests ratably over 3 years from grant date |
| Reference scale from 2024 annual meeting | Options to acquire 84,746 shares and 67,416 RSUs per non-employee director (illustrative of grant sizing at that meeting) |
Other Directorships & Interlocks
| Category | Disclosure |
|---|---|
| Current public company boards | None disclosed in CELU’s 2025 proxy or June 2025 appointment 8‑K |
| Committee roles at other public companies | None disclosed |
| Noted affiliations | Registered lobbyist for the Roman Catholic Diocese of Brooklyn and DeSales Media Group |
Expertise & Qualifications
- Government/policy interface; intergovernmental affairs leadership and registered lobbying experience .
- Audit Committee financial expert designation (SEC) and Nasdaq financial sophistication .
- Independence under Nasdaq/SEC standards .
- Audit oversight remit includes cybersecurity and data privacy risk oversight .
Equity Ownership
| Ownership Detail | Amount |
|---|---|
| Total beneficial ownership (shares) | 0 |
| Ownership % of outstanding | — (not applicable) |
| Pledged shares | None disclosed; company policy prohibits pledging and hedging without advance audit committee approval |
| Section 16 filings context | 2024 compliance list predates his appointment; no issues disclosed for Mr. LeVien there |
Governance Assessment
- Positives: Independent director with Audit Chair role and audit committee financial expert designation enhances board financial oversight; audit remit explicitly covers cybersecurity/data privacy risks; no Item 404 related-party transactions involving Mr. LeVien at appointment; board-wide independence (except CEO) bolsters governance .
- Alignment/watch items: Beneficial ownership reported at 0 shares as of Oct 30, 2025; alignment expected to increase upon initial/annual director equity grants per policy (monitor grants at/after the 2025 annual meeting) . His ongoing lobbying affiliations represent potential perception risk; however, the company disclosed no related-party transactions involving him at appointment, and the Audit Committee oversees related-person transactions under a formal policy .
- Board structure: CEO serves as Board Chair; no lead independent director disclosed. The board cites benefits of combined CEO/Chair but investors may prefer robust independent committee leadership (notably, Mr. LeVien chairs Audit) .
No education credentials or director-specific attendance were disclosed for Mr. LeVien in the filings reviewed; items not disclosed are omitted per instruction.